A study has shown that breast cancer patients who take aromatase inhibitors, a common breast cancer medication, will find semagludtides dont work for themwhich is unfortunate, since those meds cause weight gain
Such adverse effects may be linked to the loss of lean mass, circadian misalignment and poor dietary choices associated with reward-based eating in genetically-predisposed individuals (Figure 1)
When it comes to GLP-1 medications like Ozempic and Wegovy, thats the question more providers and patients are starting to ask
In animal studies, Zepbound has been linked to thyroid cancer, but its not known if this risk applies to humans
This applies to every product, but especially the fiber-based ones
Nausea, vomiting, diarrhoea, stomach pain, constipation and headache are among the most common side effects